The nation of Zimbabwe has rejected a substantial US healthcare agreement valued at 367 million US dollars (£272m) over five years due to the United States' request for sensitive biological samples.
This rejection became public following a official document dated December was disclosed, indicating that President Emmerson Mnangagwa believed the deal was "lopsided".
An official spokesman has since stated that the United States was requesting biological samples for research and commercial gain while refused to guarantee the resulting advantages from future medical innovations.
"We are forced to start the challenging and unfortunate process of scaling back our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the US had provided over $1.9bn in health funding to Zimbabwe during the past two decades.
A medical body in Zimbabwe has urged further negotiations to reach a agreement acceptable to both sides so the country's vital HIV programme can continue.
Wider Context
This rejection comes after a similar case in neighbouring Kenya, where a court halted a similar deal with the US after legal challenges were raised about the safety of Kenyans' medical information.
After resuming the presidency recently, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).
USAID had overseen aid for the US government, but Trump stated its expenditure was "inefficient" and his administration was pursuing direct bilateral deals to enhance openness and responsibility.
According to statements, 16 nations in Africa have so far signed these new agreements, representing over $18.3bn in committed funds.
Specifics of the Declined Deal
This assistance for Zimbabwe would have supported "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this collaboration would have delivered significant benefits for the people of Zimbabwe, especially the 1.2 million presently on HIV treatment via US-supported programmes," Tremont commented.
However, official spokesman Nick Mangwana argued the proposed deal was "unequal".
"Zimbabwe was being asked to surrender its biological resources and data indefinitely, without any corresponding guarantee of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that might be developed from that provided information," he stated.
"In essence, our country would provide the raw materials for scientific discovery without any assurance that the final treatments would be accessible to our citizens if a future pandemic arise."
National Interest and International Frameworks
Mangwana further noted that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were disrupting systems already established via the international health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system created to manage future global health emergencies.
"This mechanism is designed to guarantee that when a country provides its samples, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the capability to create them."
Zimbabwe's reservations over the US deal "should not be misconstrued as hostility towards the US," he added.
"We welcome continued dialogue with our American counterparts on how future collaboration might be structured in a manner that respects the sovereignty and interests of both nations."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the government's concerns, but urged that negotiations need to persist since much of the nation's Aids initiatives relied on international support.
"If specific concerns arise, including those relating to data governance or agreement terms, these can often be resolved via detailed discussion and mutually agreed protections," it added.
The situation emphasises the continuing tensions between receiving much-needed foreign assistance and protecting a country's data in an ever more interconnected world.